Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for joddes in registrations and monthly communication reports

Refine monthly communication reports results by

Type
Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (46)
Results: 1-46 | Export
  1. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Delaney Cullinan, Earnscliffe Strategy Group
    Registration: 3 of 3 (2024-03-27 to present)
    Posted: 2024-03-27
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  2. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Delaney Cullinan, Earnscliffe Strategy Group
    Registration: 2 of 3 (2024-03-26 to 2024-03-27)
    Posted: 2024-03-26
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  3. Pharmascience Inc.
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 3 of 3 (2024-03-26 to present)
    Posted: 2024-03-27
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  4. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Beth Palmer, Earnscliffe Strategies
    Registration: 2 of 2 (2024-03-26 to present)
    Posted: 2024-03-27
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  5. Pharmascience Inc.
    Type: Consultant
    Lobbyist: ANDRE ALBINATI, Earnscliffe Strategy Group
    Registration: 4 of 4 (2024-03-26 to present)
    Posted: 2024-03-26
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  6. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 21 of 22 (2023-06-19 to 2023-06-19)
    Posted: 2023-06-21
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 5
  7. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 20 of 22 (2023-06-01 to 2023-06-19)
    Posted: 2023-06-15
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  8. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Delaney Cullinan, Earnscliffe Strategy Group
    Registration: 1 of 3 (2023-05-02 to 2024-03-26)
    Posted: 2023-05-02
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  9. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 19 of 22 (2023-03-13 to 2023-06-01)
    Posted: 2023-03-14
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  10. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 18 of 22 (2023-01-03 to 2023-03-13)
    Posted: 2023-01-16
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  11. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Beth Palmer, Earnscliffe Strategies
    Registration: 1 of 2 (2022-10-18 to 2024-03-26)
    Posted: 2022-10-19
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  12. Pharmascience Inc.
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 2 of 3 (2022-06-20 to 2024-03-26)
    Posted: 2022-06-20
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  13. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Mary Anne Carter, Earnscliffe Strategy Group
    Registration: 2 of 2 (2022-06-20 to 2023-05-19)
    Posted: 2022-06-20
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  14. Pharmascience Inc.
    Type: Consultant
    Lobbyist: ANDRE ALBINATI, Earnscliffe Strategy Group
    Registration: 3 of 4 (2022-06-20 to 2024-03-26)
    Posted: 2022-06-20
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  15. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 17 of 22 (2022-04-19 to 2023-01-03)
    Posted: 2022-04-19
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  16. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 16 of 22 (2021-11-08 to 2022-04-19)
    Posted: 2021-11-08
    Subject matter details: 7
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  17. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Muhammad Ali, Crestview Strategy
    Registration: 1 of 1 (2021-06-07 to 2022-06-01)
    Posted: 2021-06-08
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  18. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 15 of 22 (2021-04-30 to 2021-11-08)
    Posted: 2021-04-30
    Subject matter details: 6
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  19. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Lena Gahwi, Crestview Strategy
    Registration: 1 of 1 (2021-03-03 to 2021-03-30)
    Posted: 2021-04-20
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  20. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 13 of 22 (2021-01-20 to 2021-01-20)
    Posted: 2021-01-20
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  21. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 12 of 22 (2021-01-20 to 2021-01-20)
    Posted: 2021-01-20
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  22. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 14 of 22 (2021-01-20 to 2021-04-30)
    Posted: 2021-03-12
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  23. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Chad Rogers, Crestview Strategy Inc.
    Registration: 2 of 2 (2021-01-18 to 2022-10-27)
    Posted: 2021-01-18
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  24. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Ashton Arsenault, Crestview Strategy
    Registration: 1 of 1 (2020-12-03 to 2023-01-17)
    Posted: 2020-12-03
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  25. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 11 of 22 (2020-10-16 to 2021-01-20)
    Posted: 2020-10-19
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  26. TELESAT CANADA
    Type: Consultant
    Lobbyist: Chad Rogers, Crestview Strategy Inc.
    Registration: 2 of 5 (2020-08-25 to 2020-10-01)
    Posted: 2020-08-25
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  27. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Susie Heath, Crestview Strategy
    Registration: 2 of 2 (2020-04-15 to 2020-12-04)
    Posted: 2020-04-30
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  28. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Patricia Sibal, Crestview Strategy
    Registration: 1 of 1 (2019-08-06 to 2021-09-30)
    Posted: 2019-08-07
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  29. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Susie Heath, Crestview Strategy
    Registration: 1 of 2 (2019-07-02 to 2020-01-16)
    Posted: 2019-07-03
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  30. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Chad Rogers, Crestview Strategy Inc.
    Registration: 1 of 2 (2019-05-23 to 2021-01-18)
    Posted: 2019-05-27
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  31. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 10 of 22 (2019-04-04 to 2020-01-16)
    Posted: 2019-05-03
    Subject matter details: 4
    Government institutions: 4
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  32. Pharmascience Inc.
    Type: Consultant
    Lobbyist: Jason Clark, Crestview Strategy
    Registration: 1 of 1 (2018-09-10 to 2021-04-25)
    Posted: 2018-09-17
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  33. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 9 of 22 (2014-06-16 to 2014-12-02)
    Posted: 2014-06-17
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  34. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 8 of 22 (2014-02-27 to 2014-06-16)
    Posted: 2014-03-14
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7
  35. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 7 of 22 (2013-05-27 to 2014-02-27)
    Posted: 2013-05-27
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  36. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 6 of 22 (2012-07-16 to 2013-05-27)
    Posted: 2012-07-16
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  37. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 5 of 22 (2012-03-23 to 2012-07-16)
    Posted: 2012-03-23
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  38. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 4 of 22 (2012-03-23 to 2012-03-23)
    Posted: 2012-03-23
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  39. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 3 of 22 (2011-09-02 to 2012-03-23)
    Posted: 2011-11-09
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  40. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 2 of 22 (2010-10-18 to 2011-05-02)
    Posted: 2010-11-09
    Subject matter details: 10
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  41. Pharmascience Inc
    Type: Consultant
    Lobbyist: Lori Turik, 1715570 Ontario Inc.
    Registration: 9 of 9 (2010-09-30 to 2010-11-25)
    Posted: 2010-10-13
    Subject matter details: 11
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  42. Pharmascience Inc
    Type: Consultant
    Lobbyist: Lori Turik, 1715570 Ontario Inc.
    Registration: 8 of 9 (2010-05-04 to 2010-09-30)
    Posted: 2010-07-29
    Subject matter details: 11
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  43. Pharmascience Inc
    Type: Consultant
    Lobbyist: Lori Turik, 1715570 Ontario Inc.
    Registration: 7 of 9 (2009-04-02 to 2010-05-04)
    Posted: 2009-09-17
    Subject matter details: 11
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  44. Pharmascience Inc
    Type: Consultant
    Lobbyist: Lori Turik, 1715570 Ontario Inc.
    Registration: 6 of 9 (2009-04-02 to 2009-04-02)
    Posted: 2009-04-07
    Subject matter details: 10
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  45. Pharmascience Inc
    Type: Consultant
    Lobbyist: Lori Turik, 1715570 Ontario Inc.
    Registration: 5 of 9 (2009-02-02 to 2009-04-02)
    Posted: 2009-03-25
    Subject matter details: 10
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  46. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 1 of 22 (2009-02-02 to 2009-09-03)
    Posted: 2009-04-03
    Subject matter details: 10
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
Date Modified: